News|Articles|May 14, 2025
Tufts CSDD CRA-RBQM Transition Study
Tufts CSDD is conducting new research on trends in study monitoring and data collection.
Advertisement
The Tufts Center for the Study of Drug Development (Tufts CSDD) is conducting new research aimed at understanding how study monitoring and data collection practices are changing and evolving. This research will assess how sponsor companies are approaching implementation of more centralized and risk-based monitoring approaches, and how sponsor and CRO field-based monitors are adjusting and adapting. Links to participate in this study can be found below:
- Sponsor companies, please click here to participate:
Sponsor Survey - Clinical research associates (CRAs), please click here to participate:
CRA Survey
For more information, please contact Hana Do ([email protected]).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
2
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
3
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5